ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 61

A Human ACPA Monoclonal Antibody Is Preferably Localized at Inflammatory Gingival Tissue and Activates Osteoclastogenensis in Porphyromonas Gingivalis Infected SKG Mouse

Kazuhisa Ouhara1, Tatsuhiko Ozawa2, Syuichi Munnaga1, Tatsuomi Kuranobu3, Yuta Hamamoto1, Toshihisa Kawai4, Eiji Sugiyama5 and Hidemi Kurihara1, 1Periodontal Medicine, Hiroshima University, Hiroshima, Japan, 2Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 3Clinical Immunology and Rheumatology, HIroshima University Hospital, Hiroshima, Japan, 4Periodontology, Nova Southeastern University College of Dental Medicine, Fort Lauderdale, FL, 5Department of Clinical Immunology and Rheumatology, Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ACPA and Periodontitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Periodontal disease (PD) is the chronic inflammatory disease caused by the infection of periodontopathogenic bacteria, Porphyromonas gingivalis (Pg). Pg infection is known as major pathogenic factor of some systemic diseases including rheumatoid arthritis (RA). Our group established b-gulcan (laminarin, LA) induced RA model mouse with Pg infection (Pg-RA mouse) by using SKG mouse. Pg-RA mouse showed severe arthritis and joint destruction like human RA compared with RA mouse. The cause of exacerbation of joint destruction by Pg infection was the activation of osteoclastogenesis (OCD) in Pg-RA mouse with the elevation of ACPA, IL-6, and MMP-3 in serum (Clin Exp Immunol. 2016 Nov;186(2):177-189.). Immune complex (IC) is also important in the activation of OCD. However, the involvement of IC derived from citrullinated protein (CP) in the progression of OCD is unclear. It is also unclear that the involvement of Pg pathogenic factors even if there are some enzymes possessed by Pg such as peptidyl arginine diamidase (PAD) and gingipain. In this study, the involvement of Pg which is major source of endogeneous CP in bacteria in the synthesis of IC in the periodontal tissue and joint tissue was determined. The localization and effect of ACPA in the progression of RA in model mouse were also analyzed by using a ACPA monoclonal antibody generated from RA patientfs B cell (CCP1-Ab).

Methods:

In order to induce periodontal bone loss in SKG mouse, Pg was diluted into 2% carboxyl methyl cellulose (CMC, 10f8 CFU/50 ml) and also infected into mouse oral cavity twice a week for 2 weeks with the placement of 5-0 silk thread around the maxillary second molar. As a control, CMC was only applied into oral cavity. At the same time for induction of RA, the single i.p. injection of LA was performed. In order to measure the amount of CP and ACPA, mouse was received adaptive transferred CCP-Ab1 (Arthritis Rheumatol. 2015 May;67(8):2020-31.). Then, the tissue homogenates of periodontal tissue, joint tissue, spleen and serum were determined by ELISA. The immune fluorescence microscopic analysis was also performed to determine the localization of ACPA and IC in periodontal tissue. In order to determine the effect of ACPA in the activation of OCD, bone marrow mononuclear cell (BMC) was cultured with sRANKL and M-CSF in the presence or absence of CCP-Ab1 and analyzed by TRAP staining and by CellInsight CX-5 HCS Platform for quantitative analysis of osteoclast. mRNA expression of OCD related genes in BMC was determined by quantitative RT-PCR.

Results: and Conclusion:

The distributions of ACPA in periodontal tissue, joint tissue, and spleen were observed in Pg infected periodontitis mouse by ELISA. IC was also generated in Pg infected periodontitis mouse compared with healthy mouse. The adaptive transfer of CCP1-Ab resulted in the elevation of AS compared with the that of control IgG. OCD was activated in the presence of CCP1-Ab compared with control antibody. mRNA expression of OCD related gene (traf6, nfatc1, Oscar, dc-stamp, mmp-9, and catK) in BMC was induced by CCP1-Ab. The possibility of the involvement of IC from ACPA and CP generated by Pg in periodontal tissue for the progression of bone resorption was observed in Pg-RA mouse.


Disclosure: K. Ouhara, None; T. Ozawa, None; S. Munnaga, None; T. Kuranobu, None; Y. Hamamoto, None; T. Kawai, None; E. Sugiyama, None; H. Kurihara, None.

To cite this abstract in AMA style:

Ouhara K, Ozawa T, Munnaga S, Kuranobu T, Hamamoto Y, Kawai T, Sugiyama E, Kurihara H. A Human ACPA Monoclonal Antibody Is Preferably Localized at Inflammatory Gingival Tissue and Activates Osteoclastogenensis in Porphyromonas Gingivalis Infected SKG Mouse [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/a-human-acpa-monoclonal-antibody-is-preferably-localized-at-inflammatory-gingival-tissue-and-activates-osteoclastogenensis-in-porphyromonas-gingivalis-infected-skg-mouse/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-human-acpa-monoclonal-antibody-is-preferably-localized-at-inflammatory-gingival-tissue-and-activates-osteoclastogenensis-in-porphyromonas-gingivalis-infected-skg-mouse/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology